Literature DB >> 18280699

Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.

Daniel A Nelson1, Jamie L Nirmaier, Sam J Singh, Melanie D Tolbert, Kenneth L Bost.   

Abstract

While Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) has been shown to modulate immune responses, no studies have addressed drug-induced alterations to viral infection. In this study, bone marrow-derived macrophages were exposed to MDMA, then infected with murine gammaherpesvirus-68, and the expression of monokines assessed. MDMA-induced reductions in virus-stimulated monokine mRNA expression were observed in a dose-dependent manner. In particular, IL-6 mRNA expression and secretion was significantly decreased in gammaherpesvirus-infected macrophages exposed to MDMA. Concentrations of MDMA capable of reducing monokine production did not induce significant cell death and allowed normal viral gene expression. These studies represent the first to demonstrate the ability of this drug of abuse to alter a viral-induced macrophage response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280699      PMCID: PMC4275657          DOI: 10.1016/j.bbi.2008.01.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  49 in total

1.  Transformation of mouse bone marrow cells by transfection with a human oncogene related to c-myc is associated with the endogenous production of macrophage colony stimulating factor 1.

Authors:  M D Sklar; A Tereba; B D Chen; W S Walker
Journal:  J Cell Physiol       Date:  1985-12       Impact factor: 6.384

Review 2.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

3.  Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production.

Authors:  T J Connor; D B Connelly; J P Kelly
Journal:  Immunol Lett       Date:  2001-09-03       Impact factor: 3.685

4.  Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.

Authors:  João Paulo Capela; Eduarda Fernandes; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Neurotoxicology       Date:  2007-04-27       Impact factor: 4.294

5.  Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.

Authors:  Thomas J Connor; Andrew Harkin; John P Kelly
Journal:  J Pharmacol Exp Ther       Date:  2004-08-26       Impact factor: 4.030

6.  Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.

Authors:  Roberta Pacifici; Simona Pichini; Piergiorgio Zuccaro; Magí Farré; Mireia Segura; Jordi Ortuño; Simonetta Di Carlo; Antonella Bacosi; Pere N Roset; Jordi Segura; Rafael de la Torre
Journal:  J Pharmacol Exp Ther       Date:  2004-01-13       Impact factor: 4.030

Review 7.  MDMA: a review of epidemiologic data.

Authors:  Mim J Landry
Journal:  J Psychoactive Drugs       Date:  2002 Apr-Jun

8.  Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.

Authors:  J F Nash; B L Roth; J D Brodkin; D E Nichols; G A Gudelsky
Journal:  Neurosci Lett       Date:  1994-08-15       Impact factor: 3.046

9.  MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10.

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Eur J Pharmacol       Date:  2007-07-18       Impact factor: 4.432

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  6 in total

1.  3,4-methylenedioxymethamphetamine (MDMA--Ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to Listeria monocytogenes infection in mice.

Authors:  V Ferraz-de-Paula; A Ribeiro; J Souza-Queiroz; M L Pinheiro; J F Vecina; D P M Souza; W M Quinteiro-Filho; R L M Moreau; M L S Queiroz; J Palermo-Neto
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-12       Impact factor: 4.147

2.  3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection.

Authors:  Daniel A Nelson; Sam J Singh; Amy B Young; Melanie D Tolbert; Kenneth L Bost
Journal:  Drug Alcohol Depend       Date:  2011-01-26       Impact factor: 4.492

Review 3.  Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?

Authors:  Noreen T Boyle; Thomas J Connor
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 4.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

5.  Murine gammaherpesvirus-68 expands, but does not activate, CD11b+ gr-1+ splenocytes in vivo.

Authors:  Daniel A Nelson; Vinita S Chauhan; Melanie D Tolbert; Kenneth L Bost
Journal:  J Inflamm (Lond)       Date:  2012-04-16       Impact factor: 4.981

Review 6.  Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Authors:  Attila Szabo
Journal:  Front Immunol       Date:  2015-07-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.